SCUTERI, DAMIANA
 Distribuzione geografica
Continente #
NA - Nord America 490
EU - Europa 313
AS - Asia 178
OC - Oceania 11
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 4
Totale 1.006
Nazione #
US - Stati Uniti d'America 473
IT - Italia 197
SG - Singapore 107
CN - Cina 56
GB - Regno Unito 35
DE - Germania 17
SE - Svezia 17
CA - Canada 14
FI - Finlandia 14
RU - Federazione Russa 8
NL - Olanda 7
IN - India 6
NZ - Nuova Zelanda 6
AT - Austria 5
AU - Australia 5
BR - Brasile 5
EU - Europa 4
IE - Irlanda 4
MX - Messico 3
RO - Romania 3
TH - Thailandia 3
TR - Turchia 3
CL - Cile 2
CO - Colombia 2
FR - Francia 2
BD - Bangladesh 1
HR - Croazia 1
MD - Moldavia 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
TW - Taiwan 1
UA - Ucraina 1
Totale 1.006
Città #
Santa Clara 85
Singapore 71
Chandler 48
Lawrence 38
Princeton 38
Milan 34
Chicago 32
Ashburn 28
London 27
Wilmington 22
Catanzaro 19
Helsinki 14
Redwood City 12
Beijing 11
Des Moines 11
Ann Arbor 8
Birmingham 8
Ottawa 7
Palermo 7
Rome 7
Vallefiorita 7
Florence 6
Shenzhen 6
St Petersburg 5
Amsterdam 4
Assago 4
Auckland 4
Guangzhou 4
Naples 4
Palizzi Marina 4
San Ferdinando 4
Shanghai 4
Aversa 3
Bologna 3
Dublin 3
García 3
Hackney 3
Horia 3
Rende 3
Rizziconi 3
San Nicola Manfredi 3
Springfield 3
Toronto 3
Washington 3
Wuhan 3
Bangkok 2
Boardman 2
Bogotá 2
Buccinasco 2
Catania 2
Fort Worth 2
Haining 2
Istanbul 2
Livorno 2
Los Angeles 2
Melbourne 2
Mumbai 2
Munich 2
Muzaffarpur 2
Nuremberg 2
Porirua 2
Pune 2
San Gennaro Vesuviano 2
Siler City 2
São Paulo 2
Taranto 2
Vienna 2
Alexandria 1
Andover 1
Ankara 1
Bisignano 1
Bryansk 1
Cantù 1
Castrovillari 1
Chengdu 1
Chisinau 1
Cosenza 1
Dallas 1
Dhaka 1
Edmonton 1
Fiesole 1
Garden City 1
Gatchina 1
Gravina di Catania 1
Jiaxing 1
Lakeland 1
Lima 1
Lisbon 1
Lissone 1
Mistretta 1
Monza 1
Mountain View 1
Nagold 1
Nashville 1
Niagara Falls 1
Norwalk 1
Novokuznetsk 1
Perugia 1
Phoenix 1
Prineville 1
Totale 699
Nome #
Benefits and risks associated with cannabis and cannabis derivatives use 50
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene-Related Peptide (CGRP) With Monoclonal Antibodies. 42
Effects of Palmitoylethanolamide (PEA) on Nociceptive, Musculoskeletal and Neuropathic Pain: Systematic Review and Meta-Analysis of Clinical Evidence 34
Anxiolytic-Like Effects of Bergamot Essential Oil Are Insensitive to Flumazenil in Rats. 33
Neuropharmacological Properties of the Essential Oil of Bergamot for the Clinical Management of Pain-Related BPSDs. 32
Impact of nutraceuticals on glaucoma: A systematic review 29
Focus on zavegepant: the first intranasal third-generation gepant 28
Evidence on the neuroprotective properties of brimonidine in glaucoma 28
Aging brain: In search for better neurotherapeutics 23
Antispasmodic Effect of Bergamot Essential Oil on Rat Isolated Gut Tissues 22
The need for better access to pain treatment: learning from drug consumption trends in the USA. 22
Neuropharmacology of the Neuropsychiatric Symptoms of Dementia and Role of Pain: Essential Oil of Bergamot as a Novel Therapeutic Approach. 22
Eptinezumab for the treatment of migraine 20
Effects of Aging on Formalin-Induced Pain Behavior and Analgesic Activity of Gabapentin in C57BL/6 Mice 20
Antinociceptive effect of inhalation of the essential oil of bergamot in mice 19
Evidence for accuracy of pain assessment and painkillers utilization in neuropsychiatric symptoms of dementia in Calabria region, Italy 18
Aromatherapy and Aromatic Plants for the Treatment of Behavioural and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease: Clinical Evidence and Possible Mechanisms 18
Development and translation of nanobeo, a nanotechnology-based delivery system of bergamot essential oil deprived of furocumarins, in the control of agitation in severe dementia 18
Editorial: “Novel Pain Therapeutics: From Basic Research to Clinical Translation and Rehabilitation” 18
Efficacy of Essential Oils in Relieving Cancer Pain: A Systematic Review and Meta-Analysis 17
Bergamot Essential Oil Attenuates Anxiety-Like Behaviour in Rats 17
TRANSLATION OF BERGAMOT ESSENTIAL OIL IN CLINICAL TRIAL FOR CONTROL OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA 16
Pooled Analysis of Real-World Evidence Supports Anti-CGRP mAbs and OnabotulinumtoxinA Combined Trial in Chronic Migraine 16
New trends in pharmacological control of neuropsychiatric symptoms of dementia 16
Proposal of combination therapies to treat refractory chronic migraine 16
Analgesic Characteristics of NanoBEO Released by an Airless Dispenser for the Control of Agitation in Severe Dementia 15
Essential oils for the control of the neuropsychiatric symptoms of dementia. A pharmacotechnological appraisal 15
Pharmacokinetic interactions between herbal medicines and drugs: Their mechanisms and clinical relevance 15
Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems 14
Role of 5-HT1A receptor in the anxiolytic-relaxant effects of bergamot essential oil in rodent 14
Efficacy of essential oils in pain: A systematic review and meta-analysis of preclinical evidence 14
Opioids in Post-stroke Pain: A Systematic Review and Meta-Analysis 14
2-pentadecyl-2-oxazoline prevents cognitive and social behaviour impairments in the Amyloid β-induced Alzheimer-like mice model: Bring the α2 adrenergic receptor back into play 13
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy 13
Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double-blind, placebo-controlled trial to assess the efficacy of furocoumarin-free bergamot loaded in a nanotechnology-based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia 13
Preclinical Characterization of Antinociceptive Effect of Bergamot Essential Oil and of Its Fractions for Rational Translation in Complementary Therapy 12
Biphasic Hormetic-like Effect of Lebecetin, a C-type Lectin of Snake Venom, on Formalin-induced Inflammation in Mice 12
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence 12
Diabetic retinopathy and age-related macular degeneration: a survey of pharmacoutilization and cost in Calabria, Italy. 12
Pain assessment and treatment in dementia at the time of coronavirus disease covid-19 12
Genetic variants of CGRP signaling pathway in migraine: impact on novel therapeutics 11
Targeting Neuroplasticity for the Management of Pain and Agitation in Alzheimer’s Disease via Bergamot Nanotherapy 11
New trends in pain research: from basic research to clinical translation 11
Pharmacotechnological Advances for Clinical Translation of Essential Oils for the Treatment of Pain and Agitation in Severe Dementia 10
Efficacy of therapeutic intervention with NanoBEO to manage agitation and pain in patients suffering from severe dementia: a pilot clinical trial 10
Pattern of treatment of behavioural and psychological symptoms of dementia and pain: evidence on pharmacoutilization from a large real-world sample and from a centre for cognitive disturbances and dementia 10
Exploitation of thermal sensitivity and hyperalgesia in a mouse model of dystonia 10
NAbiximols Clinical Translation To the treatment of Pain and Agitation In Severe Dementia (NACTOPAISD): Clinical trial protocol 9
Translational Value of the Transdermal Administration of Bergamot Essential Oil and of Its Fractions 9
PEA-OXA ameliorates allodynia, neuropsychiatric and adipose tissue remodeling induced by social isolation 9
Role of Spinal Cholecystokinin Octapeptide, Nociceptin/Orphanin FQ, and Hemokinin-1 in Diabetic Allodynia 9
Dementia and COVID-19: A Case Report and Literature Review on Pain Management 9
Effect of gabapentin in a neuropathic pain model in mice overexpressing human wild-type or human mutated torsin a 9
Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing 9
Dementia therapeutics and cognitive rehabilitation 8
Real world considerations for newly approved CGRP receptor antagonists in migraine care 8
Basic, Translational, and Clinical Research on Dementia 8
Essential oils-induced analgesia and related translation for the management of agitation in dementia 8
Safety of Onabotulinumtoxin A in Chronic Migraine: A Systematic Review and Meta-Analysis of Randomized Clinical Trials 8
Aging Brain: In Search of Better Neurotherapeutics 8
Pharmacological Treatment of Pain and Agitation in Severe Dementia and Responsiveness to Change of the Italian Mobilization-Observation-Behavior-Intensity-Dementia (I-MOBID2) Pain Scale: Study Protocol 8
Unbiased research is needed for rational translation of essential oils in clinic 8
Pattern of triptans use: A retrospective prescription study in Calabria, Italy 8
Motor behavior induced by bergamot essential oil in experimental tasks is differentially modulated by pretreatment with metabotropic glutamate receptor 2/3 or 5 antagonists 8
GABAA/Benzodiazepine Receptor Complex in the Dorsal Hippocampus Mediates the Effects of Chrysin on Anxiety-Like Behaviour in Female Rats 8
Evaluation of putative differences in vessel density and flow area in normal tension and high-pressure glaucoma using OCT-angiography 7
Aromatherapy in Stroke Patients: Is it Time to Begin? 7
Contribution of Histamine to Nociceptive Behaviors Induced by Intrathecally Administered Cholecystokinin-8 7
ROBOCOP (ROBOtic Care of Poststroke Pain): Study Protocol for a Randomized Trial to Assess Robot-Assisted Functional and Motor Recovery and Impact on Poststroke Pain Development 7
Opioids Resistance in Chronic Pain Management 7
Behavioral Effects of Continuously Administered Bergamot Essential Oil on Mice With Partial Sciatic Nerve Ligation 7
Hericenone C attenuates the second phase of formalin-induced nociceptive behavior by suppressing the accumulation of CD11c-positive cells in the paw epidermis via phosphorylated P65 7
Homo-AMPA in the periaqueductal grey modulates pain and rostral ventromedial medulla activity in diabetic neuropathic mice 7
Combination of anti-CGRP/CGRP-R mAbs with onabotulinumtoxin A as a novel therapeutic approach for refractory chronic migraine: a retrospective study of real-world clinical evidence and a protocol for a double-blind, randomized clinical trial to establish the efficacy and safety 7
Effect of genotype on individual response to the pharmacological treatment of glaucoma: a systematic review and meta-analysis 6
Progress in the Treatment of Migraine Attacks: From Traditional Approaches to Eptinezumab 6
Benefits and risks associated with cannabis and cannabis derivatives use 6
Requirements for Translation in Clinical Trials of Aromatherapy: The Case of the Essential Oil of Bergamot (BEO) for Management of Agitation in Severe Dementia 6
CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review 6
Transgenic Mice for the Translational Study of Neuropathic Pain and Dystonia 5
Epigenetic and nanotechnology alliance to fight stroke-induced brain damage 4
Scopolamine-Induced Memory Impairment in Mice: Effects of PEA-OXA on Memory Retrieval and Hippocampal LTP 3
Exploitation of Autophagy Inducers in the Management of Dementia: A Systematic Review 3
Editorial: Plant secondary metabolites: Potential therapeutic implications in neuropsychiatric disorders 3
Totale 1.129
Categoria #
all - tutte 16.783
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.783


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013 0 0 0 0 0 0 0 0 1 3 1 8
2020/2021102 1 8 60 5 8 7 0 5 7 0 0 1
2021/2022122 4 1 2 13 5 22 9 21 6 15 23 1
2022/2023229 78 9 7 9 17 30 6 21 23 8 17 4
2023/2024194 44 18 14 10 14 45 7 6 4 5 24 3
2024/2025459 125 58 35 21 87 104 20 9 0 0 0 0
Totale 1.129